Authors: Ueoka, H Tanimoto, M Kiura, K Tabata, M Takigawa, N Segawa, Y Takata, I Eguchi, K Okimoto, N Harita, S Kamei, H Shibayama, T Watanabe, Y Hiraki, S Harada, M

Citation: H. Ueoka et al., Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group, BR J CANC, 85(1), 2001, pp. 9-13

Authors: Tanabe, T Takata, I Kuwabara, T Warashina, M Kawasaki, H Tani, K Ohta, S Asano, S Taira, K

Citation: T. Tanabe et al., Maxizymes, novel allosterically controllable ribozymes, can be designed tocleave various substrates, BIOMACROMOL, 1(1), 2000, pp. 108-117

Authors: Takigawa, N Segawa, Y Ueoka, H Kiura, K Tabata, M Shibayama, T Takata, I Miyamoto, H Eguchi, K Harada, M

Citation: N. Takigawa et al., Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer, CANC CHEMOT, 46(4), 2000, pp. 272-278

Authors: Bessho, A Tabata, M Kiura, K Takata, I Nagata, T Fujimoto, N Kunisada, K Ueoka, H Harada, M

Citation: A. Bessho et al., Detection of occult tumor cells in peripheral blood from patients with small cell lung cancer by reverse transcriptase-polymerase chain reaction, ANTICANC R, 20(2B), 2000, pp. 1149-1154

Authors: Fujimoto, N Hiraki, A Ueoka, H Kiura, K Bessho, A Takata, I Hiramatsu, Y Ikeda, K Harada, M

Citation: N. Fujimoto et al., Intramedullary spinal cord recurrence after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation for limited-disease small cell lung cancer, LUNG CANC, 30(2), 2000, pp. 145-148

Authors: Mimoto, J Kiura, K Matsuo, K Yoshino, T Takata, I Ueoka, H Kataoka, M Harada, M

Citation: J. Mimoto et al., (-)-epigallocatechin gallate can prevent cisplatin-induced lung tumorigenesis in A/J mice, CARCINOGENE, 21(5), 2000, pp. 915-919